NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
AWS Summit: Building Resilience in Cloud, AI to Combat Cyber Threats
Federal IT leaders discussed cyber resilience, cloud, AI and rapid recovery solutions for agencies.
19m watch -
How Scientists Are Using AI to Analyze the Universe
AstroAI uses AI to identify unexpected patterns in astronomical data, helping scientists uncover new space phenomena.
13m watch -
VA Expands AI Footprint With 367 Use Cases Across Enterprise
Officials highlighted how AI is supporting areas like claims processing, clinical documentation, cybersecurity and fraud detection.
3m read -
The Rise of Platform Engineering in Government
How DevSecOps, platform engineering and AI are accelerating secure software delivery across government.
20m read
